VYRIAD INC

Where Therapies Go Viral

Rochester, United States · Founded 2017 · $95.0M raised

Employees
11–50
Founded
2017
Business Model
B2B
Website
vyriad.com
Total Funding
$95.0M
Last Round
$85.0M Series BDec 2025
Rounds
2

About

Vyriad is a clinical-stage biotechnology company founded by Mayo Clinic scientists developing engineered virus platforms for oncolytic virotherapy, in vivo gene therapy, and gene editing. The company's VSV and measles virus-based therapies are in Phase 1-2 clinical trials across multiple cancer types, with an ongoing strategic collaboration with Regeneron Pharmaceuticals.

Summary

VYRIAD INC is a Biotech company based in Rochester, United States, founded in 2017. It has raised $95.0M in total across 2 rounds, most recently a $85.0M Series B round in Dec 2025. Investors include Harry Stine, Mayo Clinic and Mirae Asset.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BDec 2025
$85.0M

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

VYRIAD INC on Indexed.vc
<a href="https://indexed.vc/companies/vyriad-inc"><img src="https://indexed.vc/api/badge/company/vyriad-inc" alt="VYRIAD INC on Indexed.vc" width="260" height="76" /></a>